Hyundai Bioscience Co., Ltd. (KOSDAQ: 048410)
South Korea
· Delayed Price · Currency is KRW
19,430
-180 (-0.92%)
Sep 11, 2024, 10:45 AM KST
Hyundai Bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 758,957 | 1,038,982 | 1,087,244 | 976,101 | 1,048,678 | 486,740 | |
Market Cap Growth | -30.91% | -4.44% | 11.39% | -6.92% | 115.45% | 166.35% | |
Enterprise Value | 781,705 | 1,031,571 | 1,069,527 | 969,321 | 1,050,097 | 491,980 | |
Last Close Price | 19060.00 | 26100.00 | 27400.00 | 25250.00 | 29200.00 | 14050.00 | |
PE Ratio | - | -71.51 | -68.16 | -46.49 | -126.96 | 434.04 | |
PS Ratio | 82.28 | 109.58 | 138.47 | 105.62 | 83.82 | 16.18 | |
PB Ratio | 15.33 | 22.95 | 18.67 | 15.85 | 20.04 | 10.19 | |
P/FCF Ratio | -220.06 | -158.67 | -60.11 | -227.78 | -59.24 | 79.62 | |
P/OCF Ratio | -229.03 | -172.92 | -65.72 | -1812.71 | 139.79 | 53.03 | |
EV/Sales Ratio | 84.60 | 108.80 | 136.22 | 104.89 | 83.93 | 16.35 | |
EV/EBITDA Ratio | -100.51 | -123.26 | -43.60 | -147.18 | -1609.84 | 78.93 | |
EV/EBIT Ratio | -88.32 | -105.22 | -40.65 | -104.35 | -237.04 | 203.31 | |
EV/FCF Ratio | -235.17 | -157.54 | -59.13 | -226.20 | -59.32 | 80.47 | |
Debt / Equity Ratio | 0.61 | 0.12 | 0.11 | 0.25 | 0.71 | 0.28 | |
Debt / EBITDA Ratio | - | - | - | - | - | 2.16 | |
Debt / FCF Ratio | -11.02 | -0.85 | -0.35 | -3.61 | -2.10 | 2.20 | |
Asset Turnover | 0.11 | 0.16 | 0.11 | 0.11 | 0.16 | 0.51 | |
Inventory Turnover | 3.78 | 1.62 | 1.63 | 1.59 | 1.19 | 3.23 | |
Quick Ratio | 0.62 | 1.77 | 2.23 | 1.73 | 3.41 | 1.77 | |
Current Ratio | 0.72 | 2.18 | 2.67 | 2.02 | 4.37 | 2.29 | |
Return on Equity (ROE) | -23.15% | -28.02% | -26.39% | -35.21% | -16.50% | 3.56% | |
Return on Assets (ROA) | -6.18% | -10.20% | -22.24% | -6.66% | -3.51% | 2.56% | |
Return on Capital (ROIC) | -6.57% | -10.63% | -23.24% | -6.97% | -3.67% | 2.73% | |
Earnings Yield | -0.87% | -1.40% | -1.45% | -2.05% | -0.79% | 0.23% | |
FCF Yield | -0.44% | -0.63% | -1.66% | -0.44% | -1.69% | 1.26% | |
Buyback Yield / Dilution | -0.52% | -1.04% | -6.64% | -2.79% | -3.67% | -2.75% | |
Total Shareholder Return | -0.52% | -1.04% | -6.64% | -2.79% | -3.67% | -2.75% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.